CARDIOVERTER
DEFIBRILLATORS
Designed to continuously monitor patients’ heart rhythm
and detect irregular heartbeats, implantable cardioverter
defibrillators (ICDs) deliver electrical signals and controlled shocks
in order to restore a normal heart rhythm when necessary.

GALLANT™ ICD SOLUTIONS
Gallant™ single and dual chamber ICDs feature a 40 Joules (J) maximum shock, Bluetooth® connectivity, and improved algorithms to achieve fast and effective therapy optimization for your patients.1,2
Timing is everything when shocking a patient out of ventricular fibrillation (VF). Precision Shock Technology (PST) delivers the right energy within the right time for greater first-shock success.3-11 Any energy outside this response window is wasted.
LEARN MORE ABOUT PST:

RIGHT ENERGY + RIGHT TIME
=
GREATER FIRST-SHOCK SUCCESS3
Gallant™ ICD solutions harness smartphone connectivity with long-lasting therapy and features you can intuitively program to meet your patients’ changing needs.
- Reduce inappropriate therapy with features proven to increase detection capabilities and safety margins12,13
- Encourage greater patient engagement with app-based remote monitoring
- Deliver powerful, lasting therapy with a small, contoured design that is 1.5 Tesla (T) and 3T Magnetic Resonance (MR) Conditional*

1.5T AND 3T MAGNETIC RESONANCE IMAGING (MRI)-READY SOLUTIONS*
GREATER ENGAGEMENT
Gallant™ ICD solutions offer smartphone connectivity to encourage greater patient engagement.

97% OF PATIENTS WERE COMPLIANT
using Abbott app-based remote monitoring14

ENABLES EARLIER INTERVENTION
by communicating clinically relevant events sooner

PAIRS WITH OUR SECURE myMERLINPULSE™ APP
to streamline communications with your patients, potentially reducing clinic burden and simplifying workflow

MAY SAVE YOU AND YOUR CLINIC TIME
by reducing unnecessary calls to the clinic
PATIENTS CAN USE THE myMERLINPULSE™ APP TO:

CHECK CONNECTIVITY STATUS
to ensure their device is being properly monitored

ACCESS DEVICE STATUS
to check battery status and device model

FIND SUPPORT RESOURCES
such as clinic information, technical support numbers and frequently asked questions (FAQs) site

SEND DATA MANUALLY
as instructed by a clinician

VIEW HISTORY
of scheduled data transmissions, connection issues and patient notifications
SECURED DATA AND INFORMATION
You don’t have to worry about the safety of patient information with Abbott. The myMerlinPulse™ app transmits device status and information to the Merlin.net™ Patient Care Network through a secure, encrypted connection.
Advanced security measures include:
- Encryption when data is at rest and in motion
- Code signed and authenticated in the device, the patient app and the programmer
- Two-way authentication of credentials, for device and user
TV
TV
- Thibault B, Waddingham P, Badie N, et al. Acute Electrical Synchronization Achieved With Dynamic Atrioventricular Delays During Biventricular and Left Ventricular MultiPoint Pacing. CJC Open. 2024;7(2):166-175. doi: 10.1016/j.cjco.2024.11.003.
- Calò L, De Ruvo E, Kolb C, et al. Multipoint pacing is associated with improved prognosis and cardiac resynchronization therapy response: MORE-CRT MPP randomized study secondary analyses. Europace. 2024;26(11):euae259. doi: 10.1093/europace/euae259. Erratum in: Europace. 2025;27(2):euaf022. doi: 10.1093/europace/euaf022.
- Katcher M, Davis K, Badie N, et al. Improved ICD Shock Efficacy using Programmable Pulse Width. Presented at: Heart Rhythm Society; April 24-27, 2025.
- Swerdlow CD , Brewer JE, Kass RM, et al. Application of models of defibrillation to human defibrillation data: implications for optimizing implantable defibrillator capacitance. Circulation. 1997;96(9):2813-22. doi: 10.1161/01.cir .96.9.2813.
- Ellenbogen K, Wilkoff G, Kay G, et al. (2007). Clinical Cardiac Pacing, Defibrillation, and Resynchronization Therapy (3rd ed.). Elsevier Saunders; 542-547. ISBN-13: 978-1- 4160-2536-8.
- Kawata U , Birgersdotter-Green U . (2018). Ventricular Fibrillation and Defibrillation, Encyclopedia of Cardiovascular Research and Medicine. Elsevier, 674-682. ISBN 9780128051542. doi: 10.1016/B978-0-12-809657-4.99764-3.
- Efimov I, Kroll M, Tchou P . (2009). Cardiac Bioelectric Therapy. Springer, 468-472. ISBN 978-0-387-79403-7.
- Kroll M, Lehmann M. (1996). Implantable Cardioverter Defibrillator Therapy. Kluwher Academic Publishers, 68 -69.
- Gold MR, Shorofsky SR. Strength-duration relationship for human transvenous defibrillation. Circulation. 1997;96(10):3517-20. doi: 10.1161/01.cir .96.10.3517.
- Kroll MW , Swerdlow CD . Optimizing defibrillation waveforms for ICDs. J Interv Card Electrophysiol. 2007;18(3):247-63. doi: 10.1007/s10840-007-9095-z.
- Doshi SK, Pittaro MD , Reeves R, et al. Efficacy of tuned waveforms based on different membrane time constants on defibrillation thresholds: primary results from the POWER trial. Pacing Clin Electrophysiol. 2012;35(10):1253-61. doi: 10.1111/j. 1540-8159.2012.03500.x.
- Gabriels J, Budzikowski AS, Kassotis JT. Defibrillation waveform duration adjustment increases the proportion of acceptable defibrillation thresholds in patients implanted with single-coil defibrillation leads. Cardiology. 2013;124(2):71-75. doi: 10.1159/000345776.
- Veltmann C, Wöhrle , Busch M, et al. Reduction of inappropriate shocks of ICDs with enhanced SVT discriminators. Presented at: Europace; 2017.
- Piorkowski C, et al. Early real-world adoption of mobile remote monitoring using the Confirm Rx Insertable Cardiac Monitor. Poster presented at: Asia Pacific Heart Rhythm Society; 2018.
- Device IFUs: Abbott Tachycardia Devices Help Manual (ARTEN600307504A), Medtronic manuals (Evera‡ XT, Amplia‡, Cobalt‡ XT, and Crome‡), Boston Scientific manuals (NG4 Tachy ICD, NG4 Tachy CRT-D), and Biotronik (Rivacor‡ ICDs and CRT-Ds, Acticor‡ ICDs and CRT-Ds).